We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
FTAI Infrastructure
FIP
$500M
| $1.31M | ﹤0.01% |
266,105
+2,048
| +0.8% | +$11.5K |
|
|
ALX
2427
Alexander's
ALX
$1.4B
| $1.31M | ﹤0.01% |
5,565
-163
| -3% | -$38.8K |
|
2428
NETGEAR
NTGR
$669M
| $1.31M | ﹤0.01% |
60,166
-4,241
| -7% | -$91.5K |
|
2429
Great Southern Bancorp
GSBC
$863M
| $1.31M | ﹤0.01% |
20,808
+123
| +0.6% | +$7.69K |
|
2430
ArriVent BioPharma
AVBP
$1.48B
| $1.31M | ﹤0.01% |
56,839
+3,221
| +6% | +$72.7K |
|
2431
Atea Pharmaceuticals
AVIR
$379M
| $1.31M | ﹤0.01% |
243,103
+2,515
| +1% | +$11.6K |
|
2432
Critical Metals Corp
CRML
$853M
| $1.31M | ﹤0.01% |
164,643
-548,423
| -77% | -$6.32M |
|
2433
Hertz
HTZ
$572M
| $1.31M | ﹤0.01% |
283,298
-4,675
| -2% | -$22.6K |
|
|
FFWM
2434
DELISTED
First Foundation Inc
FFWM
| $1.31M | ﹤0.01% |
221,220
+18,801
| +9% | +$114K |
|
2435
Phathom Pharmaceuticals
PHAT
$912M
| $1.3M | ﹤0.01% |
117,301
+8,455
| +8% | +$107K |
|
2436
Tonix Pharmaceuticals
TNXP
$157M
| $1.3M | ﹤0.01% |
94,561
+1,159
| +1% | +$17.8K |
|
2437
Kiniksa Pharmaceuticals
KNSA
$4.83B
| $1.3M | ﹤0.01% |
26,948
+6,715
| +33% | +$297K |
|
2438
GSK
GSK
$103B
| $1.3M | ﹤0.01% |
23,472
-1,029
| -4% | -$55.8K |
|
|
BOW
2439
Bowhead Specialty Holdings
BOW
$1.02B
| $1.29M | ﹤0.01% |
57,716
+602
| +1% | +$14.6K |
|
|
CTLP
2440
DELISTED
Cantaloupe
CTLP
| $1.29M | ﹤0.01% |
119,122
+3,584
| +3% | +$37.9K |
|
|
HTB
2441
HomeTrust Bancshares
HTB
$818M
| $1.29M | ﹤0.01% |
30,140
+2,492
| +9% | +$107K |
|
2442
Accel Entertainment
ACEL
$979M
| $1.28M | ﹤0.01% |
117,565
-5,589
| -5% | -$63K |
|
|
NXDT
2443
NexPoint Diversified Real Estate Trust
NXDT
$281M
| $1.27M | ﹤0.01% |
272,990
+110,716
| +68% | +$496K |
|
2444
Heartland Express
HTLD
$1.11B
| $1.27M | ﹤0.01% |
121,787
+1,073
| +0.9% | +$11.3K |
|
2445
BlueLinx
BXC
$455M
| $1.27M | ﹤0.01% |
23,371
+190
| +0.8% | +$12.5K |
|
2446
Intercorp Financial Services
IFS
$6.63B
| $1.27M | ﹤0.01% |
25,222
| – | – |
|
2447
Sweetgreen
SG
$713M
| $1.27M | ﹤0.01% |
243,770
-8,096
| -3% | -$49.2K |
|
|
NFBK
2448
DELISTED
Northfield Bancorp
NFBK
| $1.26M | ﹤0.01% |
93,204
+773
| +0.8% | +$9.96K |
|
2449
Coty
COTY
$2.33B
| $1.26M | ﹤0.01% |
627,785
+154,067
| +33% | +$414K |
|
2450
Miller Industries
MLR
$586M
| $1.26M | ﹤0.01% |
27,617
+216
| +0.8% | +$9.22K |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.